Coloma Jason V — SEC insider filings
SEC reporting owner CIK 1676170. 12 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2025-09-24 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 10 filings — 264,146 shares, $7,230,526 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 30,311 shares @ $29.95 ($907,921) in Maze Therapeutics, Inc., filed 2026-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer, Director | 12 | — | 29 legs · 264,146 sh · $7,230,526 | 5 |
Insider filings — Coloma Jason V
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 2,257 @ $30.12 · Sale (S): 336 @ $30.91 · Sale (S): 26,563 @ $30.09 · Sale (S): 5,345 @ $31.05 | EDGAR |
| 2026-10-02 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 2,593 @ $27.02 · Sale (S): 31,908 @ $27.02 | EDGAR |
| 2026-09-04 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 9,852 @ $26.38 · Sale (S): 1,375 @ $27.12 · Sale (S): 11,282 @ $26.01 · Sale (S): 129 @ $25.77 | EDGAR |
| 2026-09-03 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 2,593 @ $26.31 · Sale (S): 31,908 @ $26.29 · Option exercise (M): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 2,439 @ $26.71 · Sale (S): 154 @ $27.09 · Sale (S): 30,304 @ $26.71 · Sale (S): 1,604 @ $27.09 | EDGAR |
| 2026-07-02 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 2,593 @ $29.98 · Sale (S): 30,311 @ $29.95 · Sale (S): 1,597 @ $30.44 | EDGAR |
| 2026-06-24 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 1,953 @ $26.00 · Sale (S): 2,040 @ $26 · Sale (S): 23,865 @ $26.05 | EDGAR |
| 2026-06-03 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 6,090 @ $26.20 · Sale (S): 553 @ $26.24 | EDGAR |
| 2026-05-27 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 4,504 @ $26.00 · Sale (S): 2,478 @ $26 · Sale (S): 25,582 @ $26.02 | EDGAR |
| 2026-05-18 | 4 | Maze Therapeutics, Inc. (MAZE) | Sale (S): 1,822 @ $26 · Sale (S): 116 @ $26 | EDGAR |
| 2026-03-03 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1676170 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs